Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents

Journal of Nuclear Medicine

Volumn 53, Issue 10, 2012, Pages 1616-1624

  Ploessl, Karl ^a   Wang, Limin ^a   Lieberman, Brian P ^a   Qu, Wenchao ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

18F; Glutamic acid glutamate; Glutamine; PET; Tumor imaging

Indexed keywords

4 FLUOROGLUTAMIC ACID F 18; 4 FLUOROGLUTAMINE F 18; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; GLUTAMIC ACID; GLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG RETENTION; DRUG STRUCTURE; DRUG UPTAKE; GENE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SLC1A5 GENE; SLC7A11 GENE; TRANSPORT KINETICS; TUMOR XENOGRAFT; ANIMAL; CELL TRANSFORMATION; CHEMISTRY; COMPARATIVE STUDY; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; RADIOCHEMISTRY; STEREOISOMERISM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FLUORINE RADIOISOTOPES; GLUTAMIC ACID; GLUTAMINE; HUMANS; MALE; MOLECULAR IMAGING; RADIOCHEMISTRY; RATS; STEREOISOMERISM;

EID: 84867036906     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.101279     Document Type: Article

References (38)

1. Tanaka Y, Nariai T, Momose T, et al. Glioma surgery using a multimodal navigation system with integrated metabolic images. J Neurosurg. 2009;110:163-172.
2. 18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
3. 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer. J Nucl Med. 2009;50:1770-1776.
4. McConathy J, Goodman Mark M. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev. 2008;27:555-573.
5. 18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. Appl Radiat Isot. 2003;58:657-666.
6. 18F]FACBC) in rat 9L gliosarcoma. Bioorg Med Chem Lett. 2010;20:2140-2143.
7. 18F]fluorocyclobutyl- 1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent. Bioorg Med Chem. 2009;17:1982-1990.
8. 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med. 2006;47:393-403.
9. 18F-fluorocyclobutyl- 1-carboxylic acid for the detection of prostate cancer. J Nucl Med. 2007;48:46-55.
10. 111In-capromab pendetide SPECT/CT. Radiology. 2011;259:852-861.
11. 18F-fluorocyclobutanecarboxylic acid in human prostate cancer. J Nucl Med. 2011;52:822-829.
12. Dang CV. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 2010;70:859-862.
13. Albihn A, Johnsen J, Henriksson M. MYC in oncogenesis and as a target for cancer therapies. Adv Cancer Res. 2010;107:163-224.
14. Dang CV. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle. 2010;9:3884-3886.
15. Dang CV, Hamaker M, Sun P, Le A, Gao P. Therapeutic targeting of cancer cell metabolism. J Mol Med. 2011;89:205-212.
16. Wellen KE, Thompson CB. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell. 2010;40:323-332.
17. Gao P, Tchernyshyov I, Chang T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458:762-765.
18. Thompson CB. Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med. 2009;360:813-815.
19. Cheng T, Sudderth J, Yang C, et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci U S A. 2011;108:8674-8679.
20. Rajagopalan KN, Deberardinis RJ. Role of glutamine in cancer: therapeutic and imaging implications. J Nucl Med. 2011;52:1005-1008.
21. Wise DR, DeBerardinis R, Mancuso A, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A. 2008;105:18782-18787.
22. Shanware NP, Mullen AR, DeBerardinis RJ, Abraham RT. Glutamine: pleiotropic roles in tumor growth and stress resistance. J Mol Med. 2011;89:229-236.
23. Qu W, Zha Z, Ploessl K, et al. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc. 2011;133:1122-1133.
24. 18F-(2S,4R) 4-fluoroglutamine. J Nucl Med. 2011;52:1947-1955.
25. 18F]- fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization. J Med Chem. 2011;54:406-410.
26. 18F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism. Clin Cancer Res. 2011;17:6000-6011.
27. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer: a PET study. J Nucl Med. 1993;34:1-6. (Pubitemid 23014212)
28. Nakanishi T, Sugawara M, Huang W, et al. Structure, function, and tissue expression pattern of human SN2, a subtype of the amino acid transport system N. Biochem Biophys Res Commun. 2001;281:1343-1348. (Pubitemid 32924567)
29. Gout PW, Buckley AR, Simms CR, Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia. 2001;15:1633-1640. (Pubitemid 32994684)
30. Kansal VK, Sharma R, Rehan G. Characterization of anionic amino acid transport systems in mouse mammary gland. Indian J Exp Biol. 2000;38:1097-1103. (Pubitemid 32139697)
31. Gambhir SS.Molecular imaging of cancer: from molecules to humans - introduction. J Nucl Med. 2008;49(suppl 2):1S-4S.
32. Ganapathy V, Thangaraju M, Prasad P. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther. 2009;121:29-40.
33. Conlon KC, Bading JR, DiResta GR, Corbally MT, Gelbard AS, Brennan MF. Validation of transport measurements in skeletal muscle with N-13 amino acids using a rabbit isolated hindlimb model. Life Sci. 1989;44:847-859. (Pubitemid 19085263)
34. Gelbard AS, Christie TR, Clarke LP, Laughlin JS. Imaging of spontaneous canine tumours with ammonia and L-glutamine labeled with N-13. J Nucl Med. 1977;18:718-723. (Pubitemid 8126930)
35. 123I-iodo-alpha- methyl-L-tyrosine SPECT in brain tumors. J Nucl Med. 2004;45:374-381.
36. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42:432-445. (Pubitemid 32207394)
37. Fuchs BC, Bode BP. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol. 2005;15:254-266. (Pubitemid 41065034)
38. Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15:6479-6483.